N-Phenyl-N′-[4-(5H-pyrrolo[3,2-d]pyrimidin-4-yloxy)phenyl]ureas as novel inhibitors of VEGFR and FGFR kinases

Add time:07/11/2019    Source:sciencedirect.com

We have recently reported the discovery of pyrrolo[3,2-d]pyrimidine derivatives 1a and 1b as potent triple inhibitors of vascular endothelial growth factor receptor (VEGFR), platelet-derived growth factor receptor (PDGFR), and Tie-2 kinases. To identify compounds having strong inhibitory activity against fibroblast growth factor receptor (FGFR) kinase, further modification was conducted using the co-crystal structure analysis of VEGFR2 and 1b. Among the compounds synthesized, urea derivative 11l having a piperazine moiety on the terminal benzene ring showed strong inhibitory activity against FGFR1 kinase as well as VEGFR2 kinase. A binding model of 11l complexed with VEGFR2 suggested that the piperazine moiety forms additional interactions with Ile1025 and His1026.

We also recommend Trading Suppliers and Manufacturers of N-[5-tert-butyl-2-(trifluoromethyl)-1,3-benzodioxol-2-yl]-N'-(2-methoxyethyl)urea (cas 692746-77-3). Pls Click Website Link as below: cas 692746-77-3 suppliers

Prev:Enhanced and stabilized n-type thermoelectric performance in α-CuAgSe by Ni doping
Next:Effects of the New Herbicide FENTRAZAMIDE (cas 158237-07-1) on the Glucose Utilization in Neurons and Erythrocytes In Vitro)